nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—myometrium—ovarian cancer	0.0218	0.133	CbGeAlD
Ibandronate—FDPS—uterine cervix—ovarian cancer	0.017	0.103	CbGeAlD
Ibandronate—FDPS—decidua—ovarian cancer	0.0162	0.0985	CbGeAlD
Ibandronate—FDPS—endometrium—ovarian cancer	0.0154	0.0935	CbGeAlD
Ibandronate—FDPS—gonad—ovarian cancer	0.0142	0.0867	CbGeAlD
Ibandronate—FDPS—uterus—ovarian cancer	0.0141	0.0862	CbGeAlD
Ibandronate—FDPS—female reproductive system—ovarian cancer	0.0127	0.0775	CbGeAlD
Ibandronate—FDPS—bone marrow—ovarian cancer	0.012	0.0731	CbGeAlD
Ibandronate—FDPS—female gonad—ovarian cancer	0.0116	0.0705	CbGeAlD
Ibandronate—FDPS—vagina—ovarian cancer	0.0115	0.0701	CbGeAlD
Ibandronate—FDPS—testis—ovarian cancer	0.0103	0.0625	CbGeAlD
Ibandronate—FDPS—lymph node—ovarian cancer	0.00744	0.0453	CbGeAlD
Ibandronate—Myalgia—Paclitaxel—ovarian cancer	0.000763	0.000913	CcSEcCtD
Ibandronate—Arthralgia—Paclitaxel—ovarian cancer	0.000763	0.000913	CcSEcCtD
Ibandronate—Nasopharyngitis—Epirubicin—ovarian cancer	0.000761	0.00091	CcSEcCtD
Ibandronate—Anxiety—Paclitaxel—ovarian cancer	0.00076	0.000909	CcSEcCtD
Ibandronate—Face oedema—Doxorubicin—ovarian cancer	0.00076	0.000909	CcSEcCtD
Ibandronate—Malnutrition—Docetaxel—ovarian cancer	0.000759	0.000909	CcSEcCtD
Ibandronate—Erythema—Docetaxel—ovarian cancer	0.000759	0.000909	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000758	0.000906	CcSEcCtD
Ibandronate—Nausea—Topotecan—ovarian cancer	0.000755	0.000903	CcSEcCtD
Ibandronate—Discomfort—Paclitaxel—ovarian cancer	0.000754	0.000902	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—ovarian cancer	0.000753	0.000901	CcSEcCtD
Ibandronate—Dry mouth—Paclitaxel—ovarian cancer	0.000746	0.000893	CcSEcCtD
Ibandronate—Diarrhoea—Vinorelbine—ovarian cancer	0.000744	0.00089	CcSEcCtD
Ibandronate—Dysgeusia—Docetaxel—ovarian cancer	0.000744	0.00089	CcSEcCtD
Ibandronate—Nausea—Melphalan—ovarian cancer	0.000739	0.000884	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000737	0.000882	CcSEcCtD
Ibandronate—Influenza—Epirubicin—ovarian cancer	0.000735	0.00088	CcSEcCtD
Ibandronate—Asthma—Epirubicin—ovarian cancer	0.000735	0.00088	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—ovarian cancer	0.000735	0.00088	CcSEcCtD
Ibandronate—Back pain—Docetaxel—ovarian cancer	0.000735	0.000879	CcSEcCtD
Ibandronate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000731	0.000875	CcSEcCtD
Ibandronate—Muscle spasms—Docetaxel—ovarian cancer	0.00073	0.000874	CcSEcCtD
Ibandronate—Infection—Paclitaxel—ovarian cancer	0.000726	0.000869	CcSEcCtD
Ibandronate—Shock—Paclitaxel—ovarian cancer	0.000719	0.000861	CcSEcCtD
Ibandronate—Dizziness—Vinorelbine—ovarian cancer	0.000719	0.00086	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000719	0.00086	CcSEcCtD
Ibandronate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000717	0.000858	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—ovarian cancer	0.000711	0.000851	CcSEcCtD
Ibandronate—Skin disorder—Paclitaxel—ovarian cancer	0.00071	0.00085	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—ovarian cancer	0.000707	0.000846	CcSEcCtD
Ibandronate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000707	0.000846	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000704	0.000842	CcSEcCtD
Ibandronate—Anaemia—Docetaxel—ovarian cancer	0.000702	0.00084	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—ovarian cancer	0.000697	0.000833	CcSEcCtD
Ibandronate—Vomiting—Vinorelbine—ovarian cancer	0.000691	0.000827	CcSEcCtD
Ibandronate—Rash—Vinorelbine—ovarian cancer	0.000685	0.00082	CcSEcCtD
Ibandronate—Dermatitis—Vinorelbine—ovarian cancer	0.000685	0.000819	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000683	0.000817	CcSEcCtD
Ibandronate—Headache—Vinorelbine—ovarian cancer	0.000681	0.000815	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—ovarian cancer	0.00068	0.000814	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—ovarian cancer	0.00068	0.000814	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—ovarian cancer	0.00068	0.000814	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—ovarian cancer	0.000671	0.000803	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000666	0.000797	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—ovarian cancer	0.000665	0.000796	CcSEcCtD
Ibandronate—Insomnia—Paclitaxel—ovarian cancer	0.000661	0.000791	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—ovarian cancer	0.000659	0.000789	CcSEcCtD
Ibandronate—Paraesthesia—Paclitaxel—ovarian cancer	0.000657	0.000786	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—ovarian cancer	0.000656	0.000784	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—ovarian cancer	0.000655	0.000784	CcSEcCtD
Ibandronate—Infestation—Epirubicin—ovarian cancer	0.000655	0.000784	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—ovarian cancer	0.000654	0.000783	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—ovarian cancer	0.000647	0.000774	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—ovarian cancer	0.000647	0.000774	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—ovarian cancer	0.000647	0.000774	CcSEcCtD
Ibandronate—Nausea—Vinorelbine—ovarian cancer	0.000646	0.000773	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—ovarian cancer	0.000644	0.000771	CcSEcCtD
Ibandronate—Dyspepsia—Paclitaxel—ovarian cancer	0.000644	0.00077	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000642	0.000768	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—ovarian cancer	0.000639	0.000764	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—ovarian cancer	0.000637	0.000762	CcSEcCtD
Ibandronate—Decreased appetite—Paclitaxel—ovarian cancer	0.000636	0.000761	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—ovarian cancer	0.000632	0.000757	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000632	0.000756	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000631	0.000755	CcSEcCtD
Ibandronate—Fatigue—Paclitaxel—ovarian cancer	0.00063	0.000754	CcSEcCtD
Ibandronate—Sweating—Epirubicin—ovarian cancer	0.000628	0.000752	CcSEcCtD
Ibandronate—Pain—Paclitaxel—ovarian cancer	0.000625	0.000748	CcSEcCtD
Ibandronate—Constipation—Paclitaxel—ovarian cancer	0.000625	0.000748	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00062	0.000742	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—ovarian cancer	0.00062	0.000742	CcSEcCtD
Ibandronate—Infection—Docetaxel—ovarian cancer	0.000616	0.000737	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—ovarian cancer	0.000615	0.000736	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—ovarian cancer	0.00061	0.00073	CcSEcCtD
Ibandronate—Shock—Docetaxel—ovarian cancer	0.00061	0.00073	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—ovarian cancer	0.000608	0.000727	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—ovarian cancer	0.000607	0.000726	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—ovarian cancer	0.000607	0.000726	CcSEcCtD
Ibandronate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000603	0.000721	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—ovarian cancer	0.000602	0.00072	CcSEcCtD
Ibandronate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000598	0.000715	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—ovarian cancer	0.000596	0.000713	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—ovarian cancer	0.000591	0.000708	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—ovarian cancer	0.000591	0.000707	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—ovarian cancer	0.00059	0.000705	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—ovarian cancer	0.000588	0.000704	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—ovarian cancer	0.000584	0.000699	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—ovarian cancer	0.000581	0.000696	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—ovarian cancer	0.000581	0.000695	CcSEcCtD
Ibandronate—Urticaria—Paclitaxel—ovarian cancer	0.000581	0.000695	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—ovarian cancer	0.00058	0.000694	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—ovarian cancer	0.000578	0.000692	CcSEcCtD
Ibandronate—Abdominal pain—Paclitaxel—ovarian cancer	0.000578	0.000692	CcSEcCtD
Ibandronate—Body temperature increased—Paclitaxel—ovarian cancer	0.000578	0.000692	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—ovarian cancer	0.000577	0.00069	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000574	0.000686	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000565	0.000676	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—ovarian cancer	0.000561	0.000671	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—ovarian cancer	0.000557	0.000666	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—ovarian cancer	0.00055	0.000658	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—ovarian cancer	0.000547	0.000655	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—ovarian cancer	0.000546	0.000653	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—ovarian cancer	0.000546	0.000653	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—ovarian cancer	0.000544	0.000651	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—ovarian cancer	0.00054	0.000647	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—ovarian cancer	0.000539	0.000645	CcSEcCtD
Ibandronate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000539	0.000645	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000538	0.000643	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—ovarian cancer	0.000536	0.000642	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000535	0.00064	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000535	0.00064	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—ovarian cancer	0.000534	0.000639	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—ovarian cancer	0.000534	0.000639	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—ovarian cancer	0.000534	0.000639	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—ovarian cancer	0.000532	0.000636	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00053	0.000634	CcSEcCtD
Ibandronate—Pain—Docetaxel—ovarian cancer	0.00053	0.000634	CcSEcCtD
Ibandronate—Constipation—Docetaxel—ovarian cancer	0.00053	0.000634	CcSEcCtD
Ibandronate—Chills—Epirubicin—ovarian cancer	0.000528	0.000632	CcSEcCtD
Ibandronate—Asthenia—Paclitaxel—ovarian cancer	0.000525	0.000628	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—ovarian cancer	0.00052	0.000622	CcSEcCtD
Ibandronate—Pruritus—Paclitaxel—ovarian cancer	0.000517	0.000619	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—ovarian cancer	0.000516	0.000617	CcSEcCtD
Ibandronate—Erythema—Epirubicin—ovarian cancer	0.000512	0.000613	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—ovarian cancer	0.000512	0.000613	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—ovarian cancer	0.000511	0.000611	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—ovarian cancer	0.000509	0.000609	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000507	0.000606	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—ovarian cancer	0.000505	0.000605	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—ovarian cancer	0.000505	0.000604	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—ovarian cancer	0.000502	0.0006	CcSEcCtD
Ibandronate—Diarrhoea—Paclitaxel—ovarian cancer	0.0005	0.000599	CcSEcCtD
Ibandronate—Back pain—Epirubicin—ovarian cancer	0.000495	0.000593	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—ovarian cancer	0.000494	0.000591	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—ovarian cancer	0.000492	0.000589	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—ovarian cancer	0.000492	0.000588	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000491	0.000587	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—ovarian cancer	0.00049	0.000586	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—ovarian cancer	0.00049	0.000586	CcSEcCtD
Ibandronate—Chills—Doxorubicin—ovarian cancer	0.000489	0.000584	CcSEcCtD
Ibandronate—Dizziness—Paclitaxel—ovarian cancer	0.000484	0.000579	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—ovarian cancer	0.000481	0.000576	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—ovarian cancer	0.000477	0.000571	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000475	0.000569	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—ovarian cancer	0.000474	0.000567	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—ovarian cancer	0.000474	0.000567	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—ovarian cancer	0.000473	0.000566	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—ovarian cancer	0.000467	0.000559	CcSEcCtD
Ibandronate—Vomiting—Paclitaxel—ovarian cancer	0.000465	0.000556	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—ovarian cancer	0.000464	0.000555	CcSEcCtD
Ibandronate—Malaise—Epirubicin—ovarian cancer	0.000462	0.000553	CcSEcCtD
Ibandronate—Rash—Paclitaxel—ovarian cancer	0.000461	0.000552	CcSEcCtD
Ibandronate—Dermatitis—Paclitaxel—ovarian cancer	0.000461	0.000551	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—ovarian cancer	0.00046	0.000551	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—ovarian cancer	0.000458	0.000549	CcSEcCtD
Ibandronate—Headache—Paclitaxel—ovarian cancer	0.000458	0.000548	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—ovarian cancer	0.000457	0.000546	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—ovarian cancer	0.000456	0.000545	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—ovarian cancer	0.000453	0.000542	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—ovarian cancer	0.000445	0.000532	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—ovarian cancer	0.000442	0.000529	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00044	0.000526	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—ovarian cancer	0.000439	0.000525	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—ovarian cancer	0.000438	0.000524	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—ovarian cancer	0.000436	0.000522	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—ovarian cancer	0.000436	0.000522	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—ovarian cancer	0.000436	0.000522	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—ovarian cancer	0.000435	0.00052	CcSEcCtD
Ibandronate—Nausea—Paclitaxel—ovarian cancer	0.000434	0.00052	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000433	0.000518	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—ovarian cancer	0.000431	0.000516	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—ovarian cancer	0.000427	0.000511	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—ovarian cancer	0.000427	0.00051	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—ovarian cancer	0.000426	0.000509	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—ovarian cancer	0.000424	0.000507	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—ovarian cancer	0.000419	0.000501	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000418	0.0005	CcSEcCtD
Ibandronate—Infection—Epirubicin—ovarian cancer	0.000415	0.000497	CcSEcCtD
Ibandronate—Shock—Epirubicin—ovarian cancer	0.000411	0.000492	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—ovarian cancer	0.00041	0.000491	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—ovarian cancer	0.00041	0.00049	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—ovarian cancer	0.000409	0.00049	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—ovarian cancer	0.000406	0.000486	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000404	0.000484	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—ovarian cancer	0.000404	0.000483	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—ovarian cancer	0.000404	0.000483	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—ovarian cancer	0.000404	0.000483	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—ovarian cancer	0.000402	0.000481	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000401	0.000479	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—ovarian cancer	0.000399	0.000477	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—ovarian cancer	0.000395	0.000472	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—ovarian cancer	0.000394	0.000471	CcSEcCtD
Ibandronate—Rash—Docetaxel—ovarian cancer	0.000391	0.000468	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—ovarian cancer	0.00039	0.000467	CcSEcCtD
Ibandronate—Headache—Docetaxel—ovarian cancer	0.000388	0.000465	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000387	0.000463	CcSEcCtD
Ibandronate—Infection—Doxorubicin—ovarian cancer	0.000384	0.00046	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000381	0.000456	CcSEcCtD
Ibandronate—Shock—Doxorubicin—ovarian cancer	0.000381	0.000455	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000379	0.000454	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—ovarian cancer	0.000378	0.000452	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—ovarian cancer	0.000376	0.00045	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—ovarian cancer	0.000375	0.000449	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000374	0.000447	CcSEcCtD
Ibandronate—Nausea—Docetaxel—ovarian cancer	0.000368	0.00044	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—ovarian cancer	0.000368	0.00044	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—ovarian cancer	0.000363	0.000435	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000361	0.000432	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—ovarian cancer	0.00036	0.000431	CcSEcCtD
Ibandronate—Constipation—Epirubicin—ovarian cancer	0.000358	0.000428	CcSEcCtD
Ibandronate—Pain—Epirubicin—ovarian cancer	0.000358	0.000428	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000352	0.000422	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—ovarian cancer	0.00035	0.000419	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—ovarian cancer	0.000347	0.000416	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—ovarian cancer	0.000345	0.000412	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000342	0.000409	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—ovarian cancer	0.000341	0.000407	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—ovarian cancer	0.000336	0.000402	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000334	0.0004	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—ovarian cancer	0.000334	0.000399	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—ovarian cancer	0.000332	0.000397	CcSEcCtD
Ibandronate—Pain—Doxorubicin—ovarian cancer	0.000331	0.000396	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—ovarian cancer	0.000331	0.000396	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—ovarian cancer	0.00033	0.000395	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—ovarian cancer	0.00033	0.000395	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000319	0.000381	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000316	0.000378	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—ovarian cancer	0.000308	0.000369	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—ovarian cancer	0.000307	0.000368	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—ovarian cancer	0.000306	0.000366	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—ovarian cancer	0.000306	0.000366	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—ovarian cancer	0.0003	0.000359	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—ovarian cancer	0.000296	0.000354	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—ovarian cancer	0.000286	0.000342	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000285	0.000341	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—ovarian cancer	0.000278	0.000332	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—ovarian cancer	0.000276	0.000331	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—ovarian cancer	0.000274	0.000327	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—ovarian cancer	0.000266	0.000318	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—ovarian cancer	0.000265	0.000317	CcSEcCtD
Ibandronate—Rash—Epirubicin—ovarian cancer	0.000264	0.000315	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—ovarian cancer	0.000263	0.000315	CcSEcCtD
Ibandronate—Headache—Epirubicin—ovarian cancer	0.000262	0.000313	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—ovarian cancer	0.000256	0.000306	CcSEcCtD
Ibandronate—Nausea—Epirubicin—ovarian cancer	0.000248	0.000297	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—ovarian cancer	0.000246	0.000294	CcSEcCtD
Ibandronate—Rash—Doxorubicin—ovarian cancer	0.000244	0.000292	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—ovarian cancer	0.000244	0.000292	CcSEcCtD
Ibandronate—Headache—Doxorubicin—ovarian cancer	0.000242	0.00029	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—ovarian cancer	0.00023	0.000275	CcSEcCtD
